Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Carcinoid Tumor Market to Rise at 10.1% CAGR During 2026-2030: Increasing Obesity Rates Spur Growth

March 30, 2026

Bile Duct Cancer Market to Grow by $1.07 Billion During 2026-2030: Key Trends, Investment Opportunities and Competitive Strategies Analyzed

March 30, 2026

General (Ret.) Frank McKenzie, Former CENTCOM Commander, Joins Pallas Speakers Bureau

March 30, 2026

MEXC Lists 20 New Ondo Tokenized Stocks with Zero-Fee Trading

March 30, 2026

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

March 30, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Alarming Study Reveals Safety Limits are Exceeded for Mercury Exposure from Dental Amalgams in Pregnant Women in the U.S.
Press Release

Alarming Study Reveals Safety Limits are Exceeded for Mercury Exposure from Dental Amalgams in Pregnant Women in the U.S.

By News RoomFebruary 14, 20243 Mins Read
Alarming Study Reveals Safety Limits are Exceeded for Mercury Exposure from Dental Amalgams in Pregnant Women in the U.S.
Share
Facebook Twitter LinkedIn Pinterest Email

CHAMPIONSGATE, Fla., Feb. 14, 2024 (GLOBE NEWSWIRE) — The International Academy of Oral Medicine and Toxicology (IAOMT) urgently highlights a concerning study, titled “Estimated mercury vapor exposure from amalgams among American pregnant women.” This study presents groundbreaking findings on the mercury vapor exposure from dental amalgams of pregnant women in the United States.

This comprehensive research, published in the journal of Human and Experimental Toxicology was based on data from the CDC’s 2015-2020 National Health and Nutrition Examination Survey (NHANES), which analyzed mercury vapor exposure in approximately 1.67 million pregnant women. Composite fillings are becoming the choice of many dentists and their patients, however 120 million Americans still have amalgam fillings. In this study, approximately 1 in 3 women were found to have 1 or more amalgam surfaces. In women with amalgam surfaces, the number of surfaces, correlated with significantly higher median daily urinary mercury excretion compared to women without amalgams. Notably, close to 30% of these women received daily mercury vapor doses from amalgams exceeding the safety limits set by the U.S. Environmental Protection Agency.

In September 2020, the FDA updated its guidelines on dental amalgam fillings, emphasizing their risks for certain vulnerable groups. They particularly noted the risk of fetal exposure during pregnancy, advising against amalgam fillings for women from fetal stage to menopause. The FDA also advised that children, individuals with neurological diseases like multiple sclerosis, Alzheimer’s, or Parkinson’s, those with impaired kidney function, and anyone with a known sensitivity to mercury or amalgam components, should avoid these fillings.

“The findings of this study underscore the need for heightened awareness of the risks to dental patients and policy shifts regarding the use of dental amalgams,” said Dr. Charles Cuprill, President of the IAOMT. “FDA warnings on amalgam are not enough. Mercury amalgam dental fillings should be banned by the FDA as they pose a serious risk to the health of all individuals who have amalgam fillings, especially pregnant women and those of reproductive age.”

Resources for dental professionals and patients regarding the negative health effects of mercury amalgam dental fillings as well as a directory of IAOMT biological dentists certified in the safe mercury amalgam removal technique (SMART) can be found at IAOMT.org

About IAOMT:
The International Academy of Oral Medicine and Toxicology (IAOMT) is a global organization dedicated to promoting safe and biocompatible dental practices. Comprising leading dentists, scientists, and allied professionals, IAOMT provides evidence-based education, research, and advocacy to improve the oral health and overall well-being of patients worldwide.

For media inquiries, please contact:
Kym Smith
IAOMT Executive Director
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/516bb543-a046-4dda-8067-1cd4d3cde8d3

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/739de208-6205-4bed-9927-be19c2cf736d

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Carcinoid Tumor Market to Rise at 10.1% CAGR During 2026-2030: Increasing Obesity Rates Spur Growth

Bile Duct Cancer Market to Grow by $1.07 Billion During 2026-2030: Key Trends, Investment Opportunities and Competitive Strategies Analyzed

General (Ret.) Frank McKenzie, Former CENTCOM Commander, Joins Pallas Speakers Bureau

MEXC Lists 20 New Ondo Tokenized Stocks with Zero-Fee Trading

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

Paraganglioma Market Trends and Investment Opportunities 2026-2030

Brian Ferdinand Joins Forbes Finance Council, Marking Key Milestone for EverForward Trading

Neuroblastoma Market Analysis Report 2026-2030 | Rising Childhood Cancer Incidence Fuels Demand | Identify Lucrative Growth Segments for Investment Purposes

Non-Muscle Invasive Bladder Cancer (NMIBC) Market to Grow by $1 Billion During 2026-2030 – Johnson & Johnson, Janssen Research & Development, and Merck & Co. Lead the Competition

Editors Picks

Bile Duct Cancer Market to Grow by $1.07 Billion During 2026-2030: Key Trends, Investment Opportunities and Competitive Strategies Analyzed

March 30, 2026

General (Ret.) Frank McKenzie, Former CENTCOM Commander, Joins Pallas Speakers Bureau

March 30, 2026

MEXC Lists 20 New Ondo Tokenized Stocks with Zero-Fee Trading

March 30, 2026

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

March 30, 2026

Latest News

Paraganglioma Market Trends and Investment Opportunities 2026-2030

March 30, 2026

Brian Ferdinand Joins Forbes Finance Council, Marking Key Milestone for EverForward Trading

March 30, 2026

Neuroblastoma Market Analysis Report 2026-2030 | Rising Childhood Cancer Incidence Fuels Demand | Identify Lucrative Growth Segments for Investment Purposes

March 30, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version